Literature DB >> 17111779

The faster the better?

Nicola Carulli1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17111779     DOI: 10.1007/bf02936531

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  19 in total

Review 1.  Use of high-dose interferon in the treatment of chronic hepatitis C.

Authors:  M L Shiffman
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 2.  Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?

Authors:  Stefan Zeuzem
Journal:  J Hepatol       Date:  2004-09       Impact factor: 25.083

Review 3.  Hepatitis C and steatosis: a reappraisal.

Authors:  A Lonardo; P Loria; L E Adinolfi; N Carulli; G Ruggiero
Journal:  J Viral Hepat       Date:  2006-02       Impact factor: 3.728

4.  Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

Authors:  A U Neumann; N P Lam; H Dahari; D R Gretch; T E Wiley; T J Layden; A S Perelson
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

5.  Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.

Authors:  M J Walsh; J R Jonsson; M M Richardson; G M Lipka; D M Purdie; A D Clouston; E E Powell
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

6.  Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.

Authors:  S Zeuzem; J H Lee; A Franke; B Rüster; O Prümmer; G Herrmann; W K Roth
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

7.  Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa.

Authors:  N P Lam; A U Neumann; D R Gretch; T E Wiley; A S Perelson; T J Layden
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

Review 8.  Treatment of hepatitis C: critical appraisal of the evidence.

Authors:  Calogero Cammà; Anna Licata; Giuseppe Cabibbo; Federica Latteri; Antonio Craxì
Journal:  Expert Opin Pharmacother       Date:  2005-03       Impact factor: 3.889

9.  Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a.

Authors:  S Zeuzem; E Herrmann; J H Lee; J Fricke; A U Neumann; M Modi; G Colucci; W K Roth
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

10.  Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C.

Authors:  Stephen A Harrison; Elizabeth M Brunt; Rizwan A Qazi; Dana A Oliver; Brent A Neuschwander-Tetri; Adrian M Di Bisceglie; Bruce R Bacon
Journal:  Clin Gastroenterol Hepatol       Date:  2005-06       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.